Defeating prostate cancer: crucial directions for research--excerpt from the report of the Prostate Cancer Progress Review Group
- PMID: 9973103
- DOI: 10.1002/(sici)1097-0045(19990201)38:2<166::aid-pros11>3.0.co;2-a
Defeating prostate cancer: crucial directions for research--excerpt from the report of the Prostate Cancer Progress Review Group
Similar articles
-
State of research for prostate cancer: Excerpt from the report of the Prostate Cancer Progress Review Group.Urology. 2001 Apr;57(4 Suppl 1):28-30. doi: 10.1016/s0090-4295(00)00932-8. Urology. 2001. PMID: 11295591
-
[Controversies in the diagnosis and treatment of cancer of the prostate. Meeting of the Uro-oncologic Group of the Spanish Association of Urology. Vigo].Actas Urol Esp. 1992 Apr;16(4):284-91. Actas Urol Esp. 1992. PMID: 1636450 Spanish. No abstract available.
-
Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001).Br J Cancer. 2003 Aug;89 Suppl 1(Suppl 1):S50-8. doi: 10.1038/sj.bjc.6601084. Br J Cancer. 2003. PMID: 12915903 Free PMC article. No abstract available.
-
Epidemiology, diagnosis and treatment of prostate cancer.Radiol Technol. 1996 Sep-Oct;68(1):39-64; quiz 65-8. Radiol Technol. 1996. PMID: 8880970 Review.
-
[Metastatic cancer of the prostate: course, diagnosis and therapeutic management].Rev Med Suisse Romande. 1995 Mar;115(3):241-7. Rev Med Suisse Romande. 1995. PMID: 7777765 Review. French. No abstract available.
Cited by
-
Metabolomic imaging of prostate cancer with magnetic resonance spectroscopy and mass spectrometry.Eur J Nucl Med Mol Imaging. 2013 Jul;40 Suppl 1(0 1):S60-71. doi: 10.1007/s00259-013-2379-x. Epub 2013 Apr 3. Eur J Nucl Med Mol Imaging. 2013. PMID: 23549758 Free PMC article. Review.
-
The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs.Nat Rev Urol. 2020 Sep;17(9):499-512. doi: 10.1038/s41585-020-0349-1. Epub 2020 Jul 22. Nat Rev Urol. 2020. PMID: 32699318 Free PMC article. Review.
-
TNFα-mediated loss of β-catenin/E-cadherin association and subsequent increase in cell migration is partially restored by NKX3.1 expression in prostate cells.PLoS One. 2014 Oct 31;9(10):e109868. doi: 10.1371/journal.pone.0109868. eCollection 2014. PLoS One. 2014. PMID: 25360740 Free PMC article.
-
Chemoprevention strategies in the prostate: an overview.Rev Urol. 2002 Spring;4(2):69-77. Rev Urol. 2002. PMID: 16985658 Free PMC article.
-
The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.J Mol Signal. 2010 Aug 18;5:14. doi: 10.1186/1750-2187-5-14. J Mol Signal. 2010. PMID: 20718984 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical